Tasso Inc., which develops devices for the self-collection of blood samples, recently raised $100m in a series B financing round, bringing its total funding raised to $131m.
The Seattle-based company said on 16 December it will use the proceeds to scale manufacturing and operations to meet the increased demand for its line of blood
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?